VanEck Associates’s CACI CACI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$152M Sell
328,972
-43,689
-12% -$22.3M 0.09% 150
2026
Q1
$203M Buy
372,661
+12,884
+4% +$7.76M 0.15% 124
2025
Q4
$192M Sell
359,777
-19,208
-5% -$10.9M 0.16% 124
2025
Q3
$189M Buy
378,985
+9,739
+3% +$4.71M 0.18% 118
2025
Q2
$176M Buy
369,246
+34,076
+10% +$15.1M 0.2% 106
2025
Q1
$123M Buy
335,170
+178,072
+113% +$68.1M 0.16% 123
2024
Q4
$63.5M Buy
157,098
+40,867
+35% +$19.9M 0.08% 161
2024
Q3
$60.9M Buy
116,231
+34,647
+42% +$16M 0.08% 161
2024
Q2
$35.1M Buy
81,584
+33,589
+70% +$13.7M 0.05% 202
2024
Q1
$18.2M Buy
47,995
+35,788
+293% +$12.7M 0.03% 295
2023
Q4
$3.95M Buy
12,207
+4,357
+56% +$1.41M 0.01% 611
2023
Q3
$2.46M Buy
7,850
+3,386
+76% +$1.13M 0.01% 704
2023
Q2
$1.52M Buy
4,464
+4,333
+3,308% +$1.35M ﹤0.01% 782
2023
Q1
$39K Buy
+131
New +$38.6K ﹤0.01% 1318

Other funds holding CACI

VanEck Associates's CACI Position: Q2 2026 in Review

VanEck Associates reduced its CACI (CACI) stake by 12% in Q2 2026, selling an estimated $22.3M and leaving 328,972 shares worth $152M. The position accounts for 0.09% of the portfolio, ranked #150.

VanEck Associates first reported a position in CACI in Q1 2023 and has held it in 14 quarters since. The position peaked at $203M in Q1 2026. 613 funds tracked by Wall St. Rank hold CACI as of Q2 2026.

  • VanEck Associates held 328,972 shares of CACI worth $152M as of Q2 2026.
  • VanEck Associates sold 43,689 CACI shares in Q2 2026, an estimated $22.3M.
  • CACI made up 0.09% of VanEck Associates's portfolio in Q2 2026, its #150 holding.
  • VanEck Associates first reported a position in CACI in Q1 2023 and has held it in 14 quarters since.
  • VanEck Associates's CACI position peaked at $203M in Q1 2026.
  • 613 funds tracked by Wall St. Rank held CACI as of Q2 2026.

Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.